The 20 Best Anemia Doctors Near Me in District of Columbia, US

Robert Nickel is a Hematologist and a Pediatrics provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 18 years. Dr. Nickel is rated as an Elite provider by MediFind in the treatment of Anemia. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Nickel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2015, Blood Banking/Transfusion Medicine: American Board Of Pathology, 2015, and Pediatrics: American Board Of Pediatrics, 2011.

Allistair Abraham is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Abraham is rated as an Elite provider by MediFind in the treatment of Anemia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Jennifer Webb is a Hematologist practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 19 years. Dr. Webb is rated as a Distinguished provider by MediFind in the treatment of Anemia. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemolytic Anemia, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Webb is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2015, Blood Banking/Transfusion Medicine: American Board Of Pathology, 2014, and Pediatrics: American Board Of Pediatrics, 2010.

Naomi L. Luban, MD, is vice chair for Faculty Affairs at Children's National. She has been an attending physician at Children’s National for more than 30 years. Dr. Luban has published more than 140 peer-reviewed journal articles and more than 40 book chapters. She has edited seven texts in pediatric transfusion medicine and is an editorial board member for Transfusion and the American Journal of Hematology. In addition, Dr. Luban is a peer-reviewer for Transfusion, JAMA, Immunohematology, the Journal of Pediatrics, Pediatric Blood and Cancer and other publications. Currently, Dr. Luban is a fellow of the American Academy of Pediatrics, the chair of the Committee on Blood Disorders in Childhood of the American Society of Hematology and a member of the board of trustees of the American Society of Pediatric Hematology/Oncology. Her clinical interests are focused in inherited platelet disorders and hemophilia. Dr. Luban lives in Maryland and has two children. Dr. Luban is rated as a Distinguished provider by MediFind in the treatment of Anemia. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemolytic Anemia, Anemia, Osteotomy, and Splenectomy. Dr. Luban is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1978 and Pediatrics: American Board Of Pediatrics, 1977.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Anemia. He is also highly rated in 61 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Kressel is board certified in American Board Of Internal Medicine.

Oswaldo Castro is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Castro is rated as a Distinguished provider by MediFind in the treatment of Anemia. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Sohail Rana is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Rana is rated as a Distinguished provider by MediFind in the treatment of Anemia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Anemia, Asthma in Children, Cerebral Hypoxia, and HIV/AIDS.

Gary Kupfer is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Kupfer is rated as a Distinguished provider by MediFind in the treatment of Anemia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Fanconi Anemia, Congenital Aplastic Anemia, Aplastic Anemia, and Anemia.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Anemia. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Monica Pearl, MD, is a board-certified American Board of Radiology diplomate with subspecialty fellowship training and certification in Diagnostic Neuroradiology and Interventional Neuroradiology. She is also a Professor of Radiology and Pediatrics at the George Washington University School of Medicine and Health Sciences. She received her undergraduate degree in mathematics from the University of North Carolina at Chapel Hill and her Doctor of Medicine from Duke University. Dr. Pearl trained in general surgery and diagnostic radiology at the George Washington University and completed fellowships in both Diagnostic Neuroradiology and Interventional Neuroradiology at the Johns Hopkins University, where she was on faculty from 2010 – 2020. Her career is dedicated to the care of children with neurovascular disorders, and she brings her expertise to Children’s National Hospital in the areas of cerebrovascular pathology, novel CNS drug delivery platforms and innovative endovascular therapies for CNS disorders including intractable seizures due to hemimegalencephaly. She has been the recipient of numerous research awards from private foundations as well as from state and federal (NIH) funding sources. Her research is focused on radiation dose reduction strategies and innovative endovascular therapies for pediatric tumors of the head, neck and spine. Dr. Pearl is a member of the American Society of Neuroradiology, a Senior Member of the Society of Neurointerventional Surgery and a member of the Core Steering Group for the Children’s Brain Tumour Drug Delivery Consortium, an international, multidisciplinary network of clinicians and researchers dedicated to developing drug delivery systems for children with brain tumors. Dr. Pearl is available for patient and physician consultation, image review, and sees patients at Children’s National in her clinic by appointment. Dr. Pearl is rated as an Experienced provider by MediFind in the treatment of Anemia. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Increased Head Circumference, Arteriovenous Malformation, Brain Aneurysm, Liver Embolization, and Thrombectomy. Dr. Pearl is board certified in Neuroradiology: American Board Of Radiology, 2012 and Diagnostic Radiology: American Board Of Radiology, 2008.

Matthew Sharron, MD, is a critical care specialist in the Division of Critical Care Medicine at Children's National Hospital. His research interests include critical illness in oncology and bone marrow transplant patients, blood product utilization, non-invasive ventilation and treatment of COVID-19 and associated complications including MIS-C. Dr. Sharron is rated as an Experienced provider by MediFind in the treatment of Anemia. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Cerebral Hypoxia, Anemia, and Bronchopulmonary Dysplasia. Dr. Sharron is board certified in Pediatric Critical Care Medicine: American Board Of Pediatrics, 2010 and Pediatrics: American Board Of Pediatrics, 2007.

Kenneth McKinley, MD, is junior faculty with a research focus in predictive analytics. At Children’s National, Dr. McKinley has built on research from his clinical fellowship, focusing on the application of complex computational models to predict the impact of system changes on pediatric Emergency Department throughput. He is now focused on the application of machine learning algorithms to develop risk prediction models for specific pediatric populations that present to the Emergency Department, including patients presenting with chief complaints related to sickle cell disease, asthma, or behavioral health. Febrile children with sickle cell disease represent a particular challenge in the Emergency Department because fever is such a common problem in childhood. Recommendations developed before the advent of conjugate vaccines continue to drive clinical practice in this high-risk population. Children with asthma or behavioral health complaints often require extended periods of emergency evaluation. By creating robust risk prediction models for patients presenting with these complaints, Dr. McKinley’s work aims to enhance care for these patients, improve patient throughput generally, and help address the national problem of ED crowding. Dr. Mckinley is rated as an Experienced provider by MediFind in the treatment of Anemia. His clinical expertise encompasses Anemia and Genetic Epilepsy with Febrile Seizures Plus (GEFS+). Dr. Mckinley is board certified in Pediatric Emergency Medicine: American Board Of Pediatrics, 2019 and Pediatrics: American Board Of Pediatrics, 2015.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Experienced provider by MediFind in the treatment of Anemia. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy. Dr. Boudadi is board certified in American Board Of Internal Medicine.

Paul Goleb is a primary care provider, practicing in Hospital Medicine in Washington, Washington, D.c.. Dr. Goleb is rated as an Experienced provider by MediFind in the treatment of Anemia. His clinical expertise encompasses Sepsis, Febrile Neutropenia, Acute Pancreatitis, Childhood Pancreatitis, and Bone Marrow Aspiration. Dr. Goleb is board certified in American Board Of Internal Medicine.

Suvankar Majumdar, MD, is chief of the Division of Hematology at Children’s National. Dr. Majumdar completed his medical training from the University of Zimbabwe College of Health Sciences and pediatric residency from Michigan State University. He previously served as the director of the Comprehensive Pediatric Sickle Cell Program at the University of Mississippi Medical Center, and also directed the Hemophilia Treatment Center. He is a recognized leader in hematology and sickle cell disease, and is passionate about taking care of patients and families living with hematological disorders. In addition to his broad clinical expertise, Dr. Majumdar is an accomplished researcher and a principal investigator of NIH-funded studies. He is currently evaluating a novel drug for treating sickle cell pain and investigating specific genetic mutations that might be associated with irregular heartbeats in this high-risk population. Dr. Majumdar is rated as an Advanced provider by MediFind in the treatment of Anemia. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Majumdar is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009.

Zenaide Quezado is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 43 years. Dr. Quezado is rated as an Advanced provider by MediFind in the treatment of Anemia. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Anemia, GM1 Gangliosidosis, and Acute Pain. Dr. Quezado is board certified in Pediatric Anesthesiology: American Board Of Anesthesiology, 2013, Anesthesiology: American Board Of Anesthesiology, 2000, and Critical Care Medicine: American Board Of Internal Medicine, 1993.

David Jacobsohn, MD, ScM, MBA, is the division chief of the Blood and Marrow Transplantation Program at Children’s National Hospital and full professor of Pediatrics at the George Washington University. He leads a program of upwards of 70 pediatric transplants per year. The program performs transplants in patients with malignant and non-malignant conditions, and has expertise with all stem cell sources including haplo-identical transplants. His expertise is in graft-versus-host disease (GvHD) clinical trials: reducing incidence of GvHD as well as novel therapies for GvHD. He has more than 10 years of experience in clinical research in pediatric GvHD. His work has included the study of novel drugs for chronic GvHD, classification criteria for chronic GvHD, and risk factor stratification in pediatric chronic GvHD. He is active in the BMT community at a national level. Examples of some current and prior roles include head of the GVHD committee for the Pediatric Blood and Marrow Transplant Consortium, member-at-large of the that Consortium, member of the Children’s Oncology Group Stem Cell Transplant Committee, member of the Clinical Trials Network State of the Science Pediatric Advisory Group. Dr. Jacobsohn has been instrumental in growing the capabilities of the Blood and Marrow Transplant Program. For example, for the last five years the program is one of the few pediatric programs performing alpha/beta T cell depletion for haploidentical transplants. This novel method for GVHD prevention has significantly improved the outcome of haploidentical BMT at Children’s National. Additionally, he has been involved with the deployment of gene therapy for hemoglobinopathies. He successfully led Children’s National to become the first program in the country to collect stem cells for a commercial sickle cell gene therapy treatment. Dr. Jacobsohn is rated as an Advanced provider by MediFind in the treatment of Anemia. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Hemoglobinopathy, Anemia, Sickle Cell Disease, and Bone Marrow Transplant. Dr. Jacobsohn is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1999.

Elizabeth Yang is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 39 years. Dr. Yang is rated as an Advanced provider by MediFind in the treatment of Anemia. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Yang is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1994 and Pediatrics: American Board Of Pediatrics, 1990.

Michael Grady is a primary care provider, practicing in Family Medicine in Washington, Washington, D.c.. Dr. Grady is rated as an Experienced provider by MediFind in the treatment of Anemia. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Dementia, Chronic Kidney Disease, Familial Hypertension, and Hypertension.

Ramsey Daher is a Gastroenterologist practicing medicine in Washington, Washington, D.c.. Dr. Daher is rated as an Experienced provider by MediFind in the treatment of Anemia. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Heartburn, Gastric Dysmotility, Familial Adenomatous Polyposis, Gastrectomy, and Colonoscopy. Dr. Daher is board certified in American Board Of Internal Medicine.